To investigate whether inflammatory pathways act as a potential link between AD and T2DM, Takeda et al. generated a dual model of AD and T2DM by crossing an APP23 transgenic mice that overexpresses human APP to leptin-deficient ob/ob mice or polygenic NSY mice as a model for diabetes. The gene discussed is LEP; the disease is diabetes mellitus.